Hill Matthew C
- SEC CIK
- 0001278675
No open-market purchases or sales filed in the past year.
Current role at each company
- APYX Apyx Medical CorpChief Financial Officeras of Jun 15, 2026
- PDSB PDS Biotechnology CorpChief Financial Officeras of Jan 6, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Hill Matthew C as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
APYX Apyx Medical Corp
Chief Financial Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 (view filing) | Aug 13, 2024 | 202 days | Hill Matthew CChief Financial Officer | PPurchase | +6.00K | $1.13 | +$6.78K | +240.0%8.50K after | Amended |
| Dec 14, 2023 (view filing) | Dec 12 | 2 days | Hill Matthew CChief Financial Officer | PPurchase | +2.50K | $2.19 | +$5.47K | New position2.50K after |
PDSB PDS Biotechnology Corp
Chief Financial Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 14, 2021 (view filing) | Dec 13 | 1 day | Hill Matthew CChief Financial Officer | PPurchase | +2.90K | $8.99 | +$26.1K | +297.4%3.88K after | 2 lots |
| Dec 14, 2021 (view filing) | Dec 13 | 1 day | Hill Matthew CChief Financial Officer | PPurchase | +200 | $9.00 | +$1.80K | +5.2%4.08K after | 2 lots |